AMYREX Trademark
Trademark Overview
On Tuesday, September 3, 2002, a trademark application was filed for AMYREX with the United States Patent and Trademark Office. The USPTO has given the AMYREX trademark a serial number of 78160140. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 22, 2003. This trademark is owned by Mindset Biopharmaceuticals (USA) Inc.. The AMYREX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations; antibody preparations; monoclonal antibodies; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; proteins; recombinant antibodies; vaccines; all of the above aforesaid goods being for the diagnosis or treatment of amyloidosis.
Scientific, medical and industrial research, all relating to amyloidosis; biochemical analysis and biochemical research both relating to amyloidosis; diagnosis of predisposition to amyloidosis; amyloidosis disease management; amyloidosis drug design; amyloidosis health care; prophylaxis and treatment of medical disorders all relating to amyloidosis; vaccination and treatment of amyloidosis patients.
General Information
| Serial Number | 78160140 |
| Word Mark | AMYREX |
| Filing Date | Tuesday, September 3, 2002 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, September 22, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations; antibody preparations; monoclonal antibodies; biological preparations; biological cultures; cell cultures; cell lines; chemical preparations; cultures of micro organisms; diagnostic preparations; enzymes; genes; proteins; recombinant antibodies; vaccines; all of the above aforesaid goods being for the diagnosis or treatment of amyloidosis. |
| Goods and Services | Scientific, medical and industrial research, all relating to amyloidosis; biochemical analysis and biochemical research both relating to amyloidosis; diagnosis of predisposition to amyloidosis; amyloidosis disease management; amyloidosis drug design; amyloidosis health care; prophylaxis and treatment of medical disorders all relating to amyloidosis; vaccination and treatment of amyloidosis patients. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 18, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 18, 2002 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Mindset Biopharmaceuticals (USA) Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10018 |
Trademark Events
| Event Date | Event Description |
| Monday, September 22, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, September 17, 2003 | ASSIGNED TO EXAMINER |
| Tuesday, January 28, 2003 | NON-FINAL ACTION MAILED |
| Saturday, January 25, 2003 | ASSIGNED TO EXAMINER |
| Friday, December 6, 2002 | PAPER RECEIVED |
